📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease (2017)

First Author: Batson J

Attributed to: Functional significance of VEGF regulation by SRPK1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acschembio.6b01048

PubMed Identifier: 28135068

Publication URI: http://europepmc.org/abstract/MED/28135068

Type: Journal Article/Review

Parent Publication: ACS Chemical Biology

Issue: 3

ISSN: 1554-8929